Cas:25445-77-6 4-Phenyl-1,2,3-thiadiazole manufacturer & supplier

We serve Chemical Name:4-Phenyl-1,2,3-thiadiazole CAS:25445-77-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Phenyl-1,2,3-thiadiazole

Chemical Name:4-Phenyl-1,2,3-thiadiazole
CAS.NO:25445-77-6
Synonyms:4-Phenyl-1,2,3-thiadiazole;1,2,3-Thiadiazole, 4-phenyl-;MFCD00087232;4-phenyl-[1,2,3]-thiadiazole;4-Phenyl-[1,2,3]thiadiazol
Molecular Formula:C8H6N2S
Molecular Weight:162.212
HS Code:2934999090

Physical and Chemical Properties:
Melting point:78ºC
Boiling point:289.3±33.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.612
PSA:54.02000
Exact Mass:162.025162
LogP:2.55

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-Phenyl-1,2,3-thiadiazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Phenyl-[1,2,3]thiadiazol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00087232 Use and application,4-Phenyl-1,2,3-thiadiazole technical grade,usp/ep/jp grade.


Related News: As a result, the Company��s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy. 4-Phenyl-1,2,3-thiadiazole manufacturer It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. 4-Phenyl-1,2,3-thiadiazole supplier The firm also has several lawyers whose reputations would carry weight with the Justice Department and the FDA, including former Attorney General Eric Holder, legal experts said. Gerald Masoudi, the Covington partner who handled the recent inquiry for Lilly, once served as the FDA’s chief counsel. Masoudi did not respond to requests for comment. 4-Phenyl-1,2,3-thiadiazole vendor It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. 4-Phenyl-1,2,3-thiadiazole factory Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.